Diabetes treatment is constantly evolving, with new therapeutic options emerging to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the https://lucywasb081980.myparisblog.com/39623115/promising-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment